Pulmonary immune responses induced in BALB/c mice by Paracoccidioides brasiliensis conidia.
Knowledge concerning the host-Paracoccidioides brasiliensis interactions is abundant. Yet, most of the experimental studies have used yeast cells to prepare the corresponding inoculum. As these cells do not represent the naturally infecting propagules, the corresponding experiments by-pass the earlier stages of such interactions. Studies done in patients, who also harbour yeast cells, suffer from the same bias. The review presented below focuses on the immune responses of BALB/c mice infected with conidia obtained from P. brasiliensis mycelial form cultures, the fungal stage most probably existing in nature. As such, the corresponding experiments would copy the onset and course of the human infection. A large number of experimental studies done by the CIB Medical and Experimental Mycology Unit in a period of almost 25 years have been revised and extracted so as to present a comprehensive record on the immune responses induced when mice are infected intranasally with the conidia. The establishment of this mouse model has permitted the analysis of the immune responses taking place during the early and late stages post-challenge. This unique model has made possible to characterize the course of the experimental disease including the inflammatory reaction, the expression of cytokines and of the various molecules associated to these responses, all of which lead to granuloma formation. The latter structure serves as a nest for the development of fibrosis. Thus, we have also obtained a glimpse on the complexity that accompanies the fibrosis, the most common sequelae of paracoccidioidomycosis. Additionally, a concerted effort has been made to appraise the whole gamut of immune factors and related molecules that directly or indirectly, contribute to shape the pathogenesis of this Latin American mycosis.
González
Angel
A
Medical and Experimental Mycology Group, Corporación para Investigaciones Biológicas, CIB, Medellin, Colombia.
Restrepo
Angela
A
Cano
Luz Elena
LE
D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D008168:Lung / Q000276:immunology* / Q000382:microbiology; D008172:Lung Diseases, Fungal / Q000276:immunology* / Q000382:microbiology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D025282:Mycelium / Q000276:immunology* / Q000472:pathogenicity; D010228:Paracoccidioides / Q000254:growth & development / Q000276:immunology* / Q000472:pathogenicity; D010229:Paracoccidioidomycosis / Q000276:immunology* / Q000382:microbiology
J Leukoc Biol. 1996 Apr;59(4):526-33
8613700
Am J Trop Med Hyg. 2004 Dec;71(6):828-30
15642978
Infect Immun. 2000 Oct;68(10):5668-72
10992469
Sabouraudia. 1981 Sep;19(3):165-78
7292205
J Clin Invest. 1987 Feb;79(2):319-26
3543052
J Immunol. 2000 Nov 15;165(10):5760-6
11067934
Curr Opin Cell Biol. 1994 Oct;6(5):752-8
7833055
Infect Immun. 2006 Jan;74(1):382-9
16368993
Pathol Microbiol (Basel). 1963;26:29-43
14015551
Biochem Biophys Res Commun. 1989 Jun 15;161(2):420-6
2735902
Clin Infect Dis. 1995 Oct;21 Suppl 2:S162-5
8845445
Biochem Biophys Res Commun. 1988 Nov 30;157(1):87-94
3196352
J Electron Microsc (Tokyo). 2001;50(1):41-9
11291959
Infect Immun. 2005 Apr;73(4):2486-95
15784595
J Immunol. 1987 Jan 15;138(2):550-65
2432129
J Immunol. 1998 Sep 15;161(6):3056-63
9743371
Infect Immun. 1977 Sep;17(3):580-5
332628
Med Mycol. 2005 Nov;43(7):637-45
16396249
Infect Immun. 1977 Jun;16(3):974-82
561033
J Med Microbiol. 1999 Aug;48(8):721-730
10450995
Int J Immunopharmacol. 1988;10(8):945-52
3145925
Rev Inst Med Trop Sao Paulo. 2007 Jan-Feb;49(1):11-6
17384814
Br J Haematol. 2005 Jun;129(5):583-96
15916680
Am J Trop Med Hyg. 1987 May;36(3):603-8
3555139
J Immunol. 2002 May 1;168(9):4593-600
11971007
Infect Immun. 2000 May;68(5):2546-52
10768942
Eur J Immunol. 1988 Oct;18(10):1587-92
3142779
Science. 1987 Jan 23;235(4787):473-6
2432665
Med Mycol. 1998 Oct;36(5):345-8
10075506
Clin Microbiol Rev. 1993 Apr;6(2):89-117
8472249